Indication
Minority health
1 clinical trial
3 products
Clinical trial
Effect of Modified, Rapid-start, DOR/3TC/TDF or DOR + FTC/TAF or BIC/FTC/TAF on Body Weight and Composition, Metabolic Risk Parameters, and Measures of Bone Strength in Treatment-Naïve Black and Hispanic Women With HIV-1 InfectionStatus: Withdrawn, Estimated PCD: 2023-05-03
Product
DOR/3TC/TDFProduct
DOR + FTC/TAFProduct
BIC/FTC/TAF